Drug Use After Emergency Department‐Initiated Injectable Buprenorphine: A Secondary Analysis of the <scp>ED</scp> ‐ <scp>INNOVATION</scp> Ancillary Safety and Feasibility Trial
Authors
Kathryn F. Hawk (ORCID: https://orcid.org/0000-0001-7435-5945)
Drug Use After Emergency Department‐Initiated Injectable Buprenorphine: A Secondary Analysis of the ED ‐ INNOVATION Ancillary Safety and Feasibility Trial
Kathryn F. Hawk, Gail D’Onofrio, Manali Phadke, Ethan Cowan et al.
Journal
Academic Emergency Medicine
Topics
Opioid Use Disorder Treatment
article
Drug Use After Emergency Department‐Initiated Injectable Buprenorphine: A Secondary Analysis of the ED ‐ INNOVATION Ancillary Safety and Feasibility Trial
Kathryn F. Hawk, Gail D’Onofrio, Manali Phadke, Ethan Cowan, Ryan McCormack, Elizabeth A. Samuels, James D Dziura, Jeanmarie Perrone, Erik S. Anderson, David A. Fiellin, Andrew A. Herring
article en
Abstract
No abstract available for this paper.
Publication Tag
Academic Emergency MedicineVol. 33(3)
Institutions
Rutgers, The State University of New Jersey (US), University of California, Los Angeles (US), Alameda Health System (US), Yale University (US), Yale New Haven Health System (US), Rutgers New Jersey Medical School (US), New York University (US), University of Pennsylvania (US)